» Articles » PMID: 31061093

GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2019 May 8
PMID 31061093
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

GP78 is an autocrine motility factor (AMF) receptor (AMFR) with E3 ubiquitin ligase activity that plays a significant role in tumor cell proliferation, motility, and metastasis. Aberrant extracellular signal-regulated kinase (ERK) activation via receptor tyrosine kinases promotes tumor proliferation and invasion. The activation of GP78 leads to ERK activation, but its underlying mechanism is not fully understood. Here, we show that GP78 is required for epidermal growth factor receptor (EGFR)-mediated ERK activation. On one hand, GP78 interacts with and promotes the ubiquitination and subsequent degradation of dual-specificity phosphatase 1 (DUSP1), an endogenous negative regulator of mitogen-activated protein kinases (MAPKs), resulting in ERK activation. On the other hand, GP78 maintains the activation status of EGFR, as evidenced by the fact that EGF fails to induce EGFR phosphorylation in GP78-deficient cells. By the regulation of both EGFR and ERK activation, GP78 promotes cell proliferation, motility, and invasion. Therefore, this study identifies a previously unknown signaling pathway by which GP78 stimulates ERK activation via DUSP1 degradation to mediate EGFR-dependent cancer cell proliferation and invasion.

Citing Articles

Sterigmatocystin declines mouse oocyte quality by inducing ferroptosis and asymmetric division defects.

Wang S, Wu X, Yang J, Peng Y, Miao F, Li M J Ovarian Res. 2024; 17(1):175.

PMID: 39198920 PMC: 11351269. DOI: 10.1186/s13048-024-01499-w.


DUSP1 interacts with and dephosphorylates VCP to improve mitochondrial quality control against endotoxemia-induced myocardial dysfunction.

Zhu H, Wang J, Xin T, Chen S, Hu R, Li Y Cell Mol Life Sci. 2023; 80(8):213.

PMID: 37464072 PMC: 11072740. DOI: 10.1007/s00018-023-04863-z.


MicroRNA-375 restrains the progression of lung squamous cell carcinoma by modulating the ERK pathway via UBE3A-mediated DUSP1 degradation.

Gan J, Zhang Y, Liu S, Mu G, Zhao J, Jiang W Cell Death Discov. 2023; 9(1):199.

PMID: 37385985 PMC: 10310764. DOI: 10.1038/s41420-023-01499-7.


Expression of autocrine motility factor receptor (AMFR) in human breast and lung invasive micropapillary carcinomas.

Xu J, Ma H, Wang Q, Zhang H Int J Exp Pathol. 2022; 104(1):43-51.

PMID: 36576071 PMC: 9845606. DOI: 10.1111/iep.12462.


Regulation of programmed death ligand 1 (PD-L1) expression by TNF-related apoptosis-inducing ligand (TRAIL) in triple-negative breast cancer cells.

Pimentel J, Zhou J, Wu G Mol Carcinog. 2022; 62(2):135-144.

PMID: 36239572 PMC: 10015553. DOI: 10.1002/mc.23471.


References
1.
Chiu C, St-Pierre P, Nabi I, Wiseman S . Autocrine motility factor receptor: a clinical review. Expert Rev Anticancer Ther. 2008; 8(2):207-17. DOI: 10.1586/14737140.8.2.207. View

2.
Kidger A, Rushworth L, Stellzig J, Davidson J, Bryant C, Bayley C . Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling. Proc Natl Acad Sci U S A. 2017; 114(3):E317-E326. PMC: 5255582. DOI: 10.1073/pnas.1614684114. View

3.
Shapiro P, Ahn N . Feedback regulation of Raf-1 and mitogen-activated protein kinase (MAP) kinase kinases 1 and 2 by MAP kinase phosphatase-1 (MKP-1). J Biol Chem. 1998; 273(3):1788-93. DOI: 10.1074/jbc.273.3.1788. View

4.
Tsai Y, Mendoza A, Mariano J, Zhou M, Kostova Z, Chen B . The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat Med. 2007; 13(12):1504-9. DOI: 10.1038/nm1686. View

5.
Wu G . Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer. Cancer Metastasis Rev. 2007; 26(3-4):579-85. DOI: 10.1007/s10555-007-9079-6. View